Cover Image

Alcohol consumption among patients diagnosed with genitourinary cancers

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Aidan Weitzner, Carlos Rivera Lopez, Joseph Cheaib, Michelle Higgins, Nirmish Singla
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	BJUI Compass
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Robotic retroperitoneal surgery in a uro‐oncology specialised centre: Translating RPLND expertise from testicular cancer to non‐genitourinary retroperitoneal tumour resection
by: Alberto Costa Silva, et al.
Published: (2026)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
by: Muhammad Haider, et al.
Published: (2025)

Urinary microbiota diversity and composition in patients with advanced renal cell cancer
by: Frederico Leal, et al.
Published: (2026)

Malignant upper urinary tract obstruction in cancer patients: A systematic review
by: Max Shah, et al.
Published: (2024)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
by: Katherina Y. Chen, et al.
Published: (2026)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
by: John Lahoud, et al.
Published: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
by: Marcus Sondermann, et al.
Published: (2025)

Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients
by: Ilfad Blazevic, et al.
Published: (2025)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
by: Liam Mannion, et al.
Published: (2024)

Exploring patient and clinician opinions, perspectives and acceptance of the use of artificial intelligence in the histological diagnosis of prostate cancer
by: Lisa Browning, et al.
Published: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
by: Sophia M. Abusamra, et al.
Published: (2025)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
by: Agnieszka Krzyzanowska, et al.
Published: (2024)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
by: Muhammad Imran, et al.
Published: (2026)

Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
by: Angelo Porreca, et al.
Published: (2025)

An international survey of contemporary practices towards fertility assessment and preservation in patients undergoing radical inguinal orchidectomy for testicular cancer
by: Abi Kanthabalan, et al.
Published: (2024)

Urodynamics assessment in patients with multiple sclerosis
by: Nicholas Faure Walker, et al.
Published: (2026)

Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
by: Laurence Klotz, et al.
Published: (2024)

Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
by: Makito Miyake, et al.
Published: (2025)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
by: Thomas Philip Cahill, et al.
Published: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
by: Ryan Sutherland, et al.
Published: (2024)

A sustainable and expedited ‘One‐Stop’ prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility
by: Lorenzo Storino Ramacciotti, et al.
Published: (2024)

Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
by: Serdar Turan, et al.
Published: (2025)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
by: Jeremy Cheng, et al.
Published: (2025)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
by: Jennifer Ward, et al.
Published: (2025)

Emerging tools for the early detection of prostate cancer
by: Muhammad Haider, et al.
Published: (2025)

A pilot study evaluating the safety and efficacy of En‐bloc holmium laser enucleation of the prostate in patients with a history of radiation therapy or high intensity focused ultrasound for management of organ confined prostate cancer with review of the literature
by: Renil S. Titus, et al.
Published: (2025)

Bibliometric analysis of focal therapy in prostate cancer research
by: Mohammed Shahait, et al.
Published: (2024)

Penile cancer in French Guiana: Epidemiology, histopathology and clinical aspects
by: Khalil Chalhoub, et al.
Published: (2025)

Patient experience of bladder cancer: A data linkage study
by: Snehadhar Shah, et al.
Published: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
by: Ailene E. Corona, et al.
Published: (2026)

Hospital variation in the treatment of cT1a renal cancer
by: Cato Caroline Bresser, et al.
Published: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
by: Nadia Rokan, et al.
Published: (2025)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
by: Eric V. Li, et al.
Published: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
by: Nikhil Mayor, et al.
Published: (2026)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
by: Ruth Pidsley, et al.
Published: (2024)

Systemic immune dysregulation in patients experiencing urogynaecological mesh failure
by: Shannon Jamieson, et al.
Published: (2026)

The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN
by: Christian Arvei Moen, et al.
Published: (2025)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
by: Geneva Pantoja, et al.
Published: (2025)

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
by: Alison Hiong, et al.
Published: (2025)